Abstract: A process for producing a composition containing biologically active follistatin from a biological source, which composition is preserved and, especially pathogen free and is storage stable, preferably at room temperature. Further, the invention relates to the composition containing biologically active follistatin, which composition is available by the production process. The invention provides a process for producing a composition containing biologically active follistatin from avian eggs, or from raw animal blood serum.
Type:
Grant
Filed:
February 12, 2013
Date of Patent:
August 26, 2014
Assignee:
Myos Corporation
Inventors:
Waldemar Buxmann, Volker Heinz, Stefan Toepfl